Peer review reports
From: Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer
Original Submission |
24 Nov 2011 |
Submitted |
Original manuscript
|
28 Nov 2011 |
Author responded |
Author comments - Charlotte Huijts
|
Resubmission - Version 2 |
28 Nov 2011 |
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
30 Nov 2011 |
Author responded |
Author comments - Charlotte Huijts
|
Resubmission - Version 4 |
30 Nov 2011 |
Submitted |
Manuscript version 4
|
Publishing |
30 Nov 2011 |
Editorially accepted |
|
30 Nov 2011 |
Article published |
10.1186/1471-2407-11-505
|
Learn about peer review